Neuren raised 22m @$2 per share only 18 months ago and today they are at around $15, I am sure everyone complained of dilution. Their market cap at the time of the raise was circa 200 million and today its 1.6bn.
This is the potential return we are talking about for Dimerix....our MC is merely 40m....and 1.6bn (which with positive interim results is a very possible deal value) is 40x return.....
- Forums
- ASX - By Stock
- DXB
- Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing, page-77
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $206.3M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $543.1K | 1.451M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 237 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 3916 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 95516 | 0.370 |
12 | 197014 | 0.365 |
13 | 301942 | 0.360 |
3 | 73000 | 0.355 |
9 | 214322 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 58662 | 3 |
0.380 | 110516 | 6 |
0.390 | 17637 | 3 |
0.395 | 142800 | 4 |
0.400 | 277640 | 8 |
Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online